Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

WIN Symposium 2013

10 - 12 Jul 2013
Le Palais des Congres, Paris, France
Role of metronomics in cancer clinical trials and practice in developing countri...
Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India
Role of metronomics in cancer clinical trials and practice in developing countries ( Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India )
19 Jul 2013
Latest on the WINTHER trial
Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France
Latest on the WINTHER trial ( Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France )
19 Jul 2013
Developments with PD1 and immunotherapy in melanoma
Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France
Developments with PD1 and immunotherapy in melanoma ( Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France )
19 Jul 2013
Challenges and opportunities for implementing personalized medicine in Brazil
Dr Rui Reis - Barretos Cancer Hospital, Barretos, Brazil
Challenges and opportunities for implementing personalized medicine in Brazil ( Dr Rui Reis - Barretos Cancer Hospital, Barretos, Brazil )
19 Jul 2013
Demonstrating the value of genomic cancer medicine
Dr Scott Ramsey - Fred Hutchinson Cancer Research Center, Seattle, USA
Demonstrating the value of genomic cancer medicine ( Dr Scott Ramsey - Fred Hutchinson Cancer Research Center, Seattle, USA )
19 Jul 2013
Strategies to address inter- and intra- patient tumour heterogeneity: PANGEA
Dr Daniel Catenacci - University of Chicago, Chicago, USA
Strategies to address inter- and intra- patient tumour heterogeneity: PANGEA ( Dr Daniel Catenacci - University of Chicago, Chicago, USA )
19 Jul 2013
Battling therapeutic resistance
Dr Gerald Batist - McGill University, Montreal, Canada
Battling therapeutic resistance ( Dr Gerald Batist - McGill University, Montreal, Canada )
19 Jul 2013
Improving predictability of clinical trial outcomes
Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada
Improving predictability of clinical trial outcomes ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )
18 Jul 2013
2013 WIN Symposium: 'Innovation to implementation'
Prof Richard Schilsky - ASCO and University of Chicago, Chicago, USA
2013 WIN Symposium: 'Innovation to implementation' ( Prof Richard Schilsky - ASCO and University of Chicago, Chicago, USA )
18 Jul 2013
Delivering stratified medicine using next generation sequencing
Dr Matthew Smith and Alice Tuff-Lacey
Delivering stratified medicine using next generation sequencing ( Dr Matthew Smith and Alice Tuff-Lacey )
18 Jul 2013
Development of information systems that identify genomic biomarkers
Dr Kris Joshi - Global VP of Healthcare, Oracle Health Sciences, Cambridge, USA
Development of information systems that identify genomic biomarkers ( Dr Kris Joshi - Global VP of Healthcare, Oracle Health Sciences, Cambridge, USA )
18 Jul 2013
Establishing immunotherapy as a standard in cancer treatment
Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA
Establishing immunotherapy as a standard in cancer treatment ( Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA )
18 Jul 2013
Molecular stratification identifies exceptional responders to therapy for pancre...
Dr David Chang – Wolfson Wohl Cancer Research Centre, University of Glasgow, UK
Molecular stratification identifies exceptional responders to therapy for pancreatic cancer ( Dr David Chang – Wolfson Wohl Cancer Research Centre, University of Glasgow, UK )
18 Jul 2013
Development of clinical decision support tools for physicians and patients
Dr Amy Abernethy – Duke University Medical Center, Durham, USA
Development of clinical decision support tools for physicians and patients ( Dr Amy Abernethy – Duke University Medical Center, Durham, USA )
18 Jul 2013
Identifying and applying molecular subgrouping in colorectal cancer
Dr Sabine Tejpar - University of Leuven, Leuven, Belgium
Identifying and applying molecular subgrouping in colorectal cancer ( Dr Sabine Tejpar - University of Leuven, Leuven, Belgium )
18 Jul 2013
Involvement in the WIN Consortium
Dr Gary Palmer, Dr Lia Tsimberidou and Dr Gerald Batist
Involvement in the WIN Consortium ( Dr Gary Palmer, Dr Lia Tsimberidou and Dr Gerald Batist )
30 Apr 2013
Implementation of individualised treatment and the WINTHER trial
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Implementation of individualised treatment and the WINTHER trial ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
The 2013 WIN Symposium
Prof Josep Tabernero and Dr Gerald Batist
The 2013 WIN Symposium ( Prof Josep Tabernero and Dr Gerald Batist )
30 Apr 2013
Importance of personalised medicine and the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Importance of personalised medicine and the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
The role of physicians and researchers in the medical community
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
The role of physicians and researchers in the medical community ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Achievements of the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Achievements of the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Goal of the 2013 WIN Symposium
Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller
Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )
23 Apr 2013